Report of the PMDA-ATC Seminar on SARS-CoV-2 Vaccine Review for the Indonesian FDA

 On October 24, the PMDA held the “PMDA-ATC Seminar on SARS-CoV-2 Vaccine Review for the Indonesian Food and Drug Authority (Indonesian FDA), Indonesia” in Jakarta, Indonesia. This seminar is one of the cooperation between the Indonesian FDA and Ministry of Health Labor and Welfare (MHLW)/PMDA based on the Memorandum of Cooperation (MoC) between the Indonesian FDA and MHLW signed August 2021.
The theme of the seminar was “Overview of consideration on SARS-CoV-2 vaccine approved in Japan”. The PMDA shared its experience in SARS-CoV-2 vaccine review with approximately 80 Indonesian FDA regulators attending online and in-person.
The PMDA continues to provide training opportunities and contributes to capacity building of the Indonesian FDA.